Flo Health, the world’s leading women’s health app, has announced a significant milestone by raising over $200 million in a Series C investment from General Atlantic, a prominent global growth investor. This investment propels Flo’s valuation beyond $1 billion, making it the first purely digital consumer women’s health app to achieve unicorn status.
Flo Health is dedicated to supporting women at every stage of their health journey, from menstruation to conception, pregnancy, and menopause. The app, which boasts over 120 doctors and health experts, offers comprehensive cycle and ovulation tracking, allowing users to monitor over 70 symptoms. Additionally, Flo provides tailored health insights, expert tips, daily visual content, and access to a private digital discussion community focused on health and wellness.
In 2023, Flo launched ‘Flo for Partners,’ a feature designed to educate and empower users’ partners with scientific insights into menstrual and reproductive health. The app’s ‘Anonymous Mode’ feature, recognized as one of Time’s Best Inventions of 2023, further protects sensitive reproductive health information.
The partnership with General Atlantic will enable Flo to expand into new user segments, including perimenopause and menopause, enhance its tech-driven health insights, and pursue strategic expansion opportunities. Flo plans to increase its R&D headcount by investing in top-tier talent across its global offices in Europe and North America.
Flo’s growth has been remarkable, with nearly 70 million monthly active users and close to 5 million paid subscribers as of June 2024. The company’s gross bookings for 2024 are expected to exceed $200 million, reflecting a 50% year-over-year increase.
Dmitry Gurski, co-founder and CEO of Flo Health, stated, “Reaching unicorn status is a significant milestone for Flo and the entire femtech industry.”
This investment solidifies Flo’s position as a frontrunner in the rapidly expanding femtech market, projected to become a $60 billion industry by 2027.
